Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT04966988

Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation

The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Heart Transplant

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

About this study

This study will enrolled 1000 HT patients, and the cardiac allograft vasculopathy will be evaluated by multimodal imaging technology. The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Heart transplantation after January 1st, 2015.

Exclusion criteria

•Age < 18 years at the time of transplantation; Died within 48 h; Heart-lung transplantation; Heart/kidney transplantation; Re-transplanted within 7 days after transplantation.

Treatment and study plan

Primary outcomes

  1. All cause death

    Time frame: up to 10 year

    All cause death after HT was obtained via telephone interview with family members; contact with his/her physicians; or hospital records

Secondary outcomes

  1. Major adverse cardiac events

    Time frame: 5 year and 10 year

    Major adverse cardiac events after the inclusion of the study was obtained via telephone interview with family members; contact with his/her physicians; or hospital records

Study contacts

Contact information is provided by the study sponsor or research team.

Li Zhang, PhD

CONTACT

[email protected]

18907131488

Shuangshuang Zhu, MD

CONTACT

[email protected]

15971428009

Sponsors and collaborators

Lead sponsor

Xie Mingxing

Other

Collaborators

  • Guangdong Provincial People's Hospital
  • Henan Provincial People's Hospital
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Shanghai Zhongshan Hospital
  • Wuhan Asia Heart Hospital

Registry information

Official study title

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Jul 19, 2021
Registry last updated
Jul 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.